Pay in 4 interest-free payments of $5.21 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
As a dual agonist for GIP and GLP-1 receptors, tirzepatide may provide superior weight reduction compared to selective GLP-1 agonists by targeting additional tissues and integrating signals from both receptor pathways in the brain.8,9 The efficacy of tirzepatide was evaluated in a phase 3 randomized withdrawal clinical trial (NCT04660643) with a 36-week, open-label tirzepatide lead-in period, followed by a 52-week, double-blind, placebo-controlled period, conducted at 70 sites in Argentina, Brazil, Taiwan, and the United States
Does Epitalon replace a healthy lifestyle
Participants losing 50+ lbs often describe transformative improvements in mobility and reductions in chronic joint pain that had limited their activities for years
Type 1 diabetes GLP-1 RA starts are currently off license and do blend better with individual consultations rather than a group setting at this time
Visit our Maintenance & Tapering Hub for provider checklists, weight tracking tools, and tapering timelines.
Lammi, Carmen, and Anna Arnoldi
US$ 25.21
US$ 27.70
US$ 22.90
US$ 29.43
